share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰製藥 | 144:擬議出售證券
美股SEC公告 ·  10/02 10:09
Moomoo AI 已提取核心訊息
Vertex Pharmaceuticals Inc. officer Jonathan Biller is set to sell 999 shares of common stock on 10/02/2024, with an aggregate market value of $461,198.34. The shares to be sold were acquired through restricted stock vesting as part of compensation from the issuer. Biller received 305 shares on 10/01/2023 and an additional 694 shares on 10/01/2024. There is no transaction history reported for the past three months. The notice of the planned sale was filed on the same date as the sale, 10/02/2024, following a plan adopted earlier on 02/13/2024.
Vertex Pharmaceuticals Inc. officer Jonathan Biller is set to sell 999 shares of common stock on 10/02/2024, with an aggregate market value of $461,198.34. The shares to be sold were acquired through restricted stock vesting as part of compensation from the issuer. Biller received 305 shares on 10/01/2023 and an additional 694 shares on 10/01/2024. There is no transaction history reported for the past three months. The notice of the planned sale was filed on the same date as the sale, 10/02/2024, following a plan adopted earlier on 02/13/2024.
Vertex Pharmaceuticals Inc.官員Jonathan Biller計劃在2024年10月2日出售999股普通股,總市值爲461,198.34美元。待售股票是作爲補償計劃的一部分,通過限制性股票歸屬而獲取。Biller於2023年10月1日收到305股股票,並於2024年10月1日再收到694股。過去三個月沒有交易記錄。計劃銷售的通知是在同一天10/02/2024提交的,之前於02/13/2024採納了該計劃。
Vertex Pharmaceuticals Inc.官員Jonathan Biller計劃在2024年10月2日出售999股普通股,總市值爲461,198.34美元。待售股票是作爲補償計劃的一部分,通過限制性股票歸屬而獲取。Biller於2023年10月1日收到305股股票,並於2024年10月1日再收到694股。過去三個月沒有交易記錄。計劃銷售的通知是在同一天10/02/2024提交的,之前於02/13/2024採納了該計劃。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息